These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31672340)

  • 1. Complement and Coagulation: Cross Talk Through Time.
    Dzik S
    Transfus Med Rev; 2019 Oct; 33(4):199-206. PubMed ID: 31672340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.
    Yuan X; Gavriilaki E; Thanassi JA; Yang G; Baines AC; Podos SD; Huang Y; Huang M; Brodsky RA
    Haematologica; 2017 Mar; 102(3):466-475. PubMed ID: 27810992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Activation of Complement and Its Role in the Pathogenesis of Thromboembolism.
    Boyce S; Eren E; Lwaleed BA; Kazmi RS
    Semin Thromb Hemost; 2015 Sep; 41(6):665-72. PubMed ID: 26305235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining coagulation-complement crosstalk: complement activation and thrombosis.
    Foley JH
    Thromb Res; 2016 May; 141 Suppl 2():S50-4. PubMed ID: 27207425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling complement-driven diseases in transgenic mice: Values and limitations.
    Ueda Y; Gullipalli D; Song WC
    Immunobiology; 2016 Oct; 221(10):1080-90. PubMed ID: 27371974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic complement inhibition – from experimental to clinical medicine.
    Lappegård KT; Bjerre A; Tjønnfjord GE; Mollnes TE
    Tidsskr Nor Laegeforen; 2015 Oct; 135(19):1745-9. PubMed ID: 26486669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementopathies.
    Baines AC; Brodsky RA
    Blood Rev; 2017 Jul; 31(4):213-223. PubMed ID: 28215731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of Complement-Mediated Damage in Hematological Disorders.
    Taylor RP; Lindorfer MA
    Semin Hematol; 2018 Jul; 55(3):118-123. PubMed ID: 30032747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. It takes two to thrombosis: Hemolysis and complement.
    Delvasto-Nuñez L; Jongerius I; Zeerleder S
    Blood Rev; 2021 Nov; 50():100834. PubMed ID: 33985796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement and coagulation: strangers or partners in crime?
    Markiewski MM; Nilsson B; Ekdahl KN; Mollnes TE; Lambris JD
    Trends Immunol; 2007 Apr; 28(4):184-92. PubMed ID: 17336159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement in hemolytic anemia.
    Brodsky RA
    Hematology Am Soc Hematol Educ Program; 2015; 2015():385-91. PubMed ID: 26637747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reincarnation of ancient links between coagulation and complement.
    Conway EM
    J Thromb Haemost; 2015 Jun; 13 Suppl 1():S121-32. PubMed ID: 26149013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The control of complement activation by the blood cells in paroxysmal nocturnal hemoglobinuria.
    Rosse WF
    Blood; 1986 Feb; 67(2):268-9. PubMed ID: 2417643
    [No Abstract]   [Full Text] [Related]  

  • 14. Complement the hemostatic system: an intimate relationship.
    Weitz IC
    Thromb Res; 2014 May; 133 Suppl 2():S117-21. PubMed ID: 24862131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New Complement Therapeutics in Complement-Related Diseases].
    Wakamiya N; Ohtani K; Hidaka Y; Inoue N
    Brain Nerve; 2019 Jun; 71(6):555-564. PubMed ID: 31171752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the alternative pathway of complement and its relation to HELLP syndrome: is it time to consider HELLP syndrome a disease of the alternative pathway.
    Vaught AJ; Braunstein E; Chaturvedi S; Blakemore K; Brodsky RA
    J Matern Fetal Neonatal Med; 2022 Apr; 35(7):1392-1400. PubMed ID: 32338085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanobodies Provide Insight into the Molecular Mechanisms of the Complement Cascade and Offer New Therapeutic Strategies.
    Zarantonello A; Pedersen H; Laursen NS; Andersen GR
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33671302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and future pharmacologic complement inhibitors.
    Risitano AM
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):561-82. PubMed ID: 26043392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eculizumab and Beyond: The Past, Present, and Future of Complement Therapeutics.
    Patriquin CJ; Kuo KHM
    Transfus Med Rev; 2019 Oct; 33(4):256-265. PubMed ID: 31703946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement activation in atypical hemolytic uremic syndrome and scleroderma renal crisis: a critical analysis of pathophysiology.
    Zuckerman R; Asif A; Costanzo EJ; Vachharajani T
    J Bras Nefrol; 2018; 40(1):77-81. PubMed ID: 29796581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.